Category Archives: U.S. Policy and Funding

Modeling tool tells when pairing responses to “big three” and neglected diseases is a win-win

By on .

The idea of pairing responses to diseases found in the global south that are so neglected that they are classified by that word with the better-funded, but still constrained responses to the so-called “Big Three” of HIV, tuberculosis and malaria, was not new. Neither was the hope that those combined efforts could streamline infectious disease control […]

Infection is unwanted souvenir from medical tourists’ trips

By on .

Three patients with post-operative infections reported by New York Health officials in May 2017 to the U.S. Centers for Disease Control and Prevention sparked an investigation that revealed 35 more patients from nine states who had traveled to the Dominican Republic for cosmetic procedures and returned with nontuberculosis myobacteria. The investigation led to the temporary […]

Spending bill boosts NIH, USAID TB, lifts Fogarty, flatlines PEPFAR, Global Fund

By on .

The spending bill for 2018 passed in the House Thursday, and the Senate early today has delivered a robust rejection of the President’s proposals to slash science spending while massively cutting funds for global infectious disease responses, with a combination of level funding and a few notable raises. They include with a $3 billion boost for […]

CDC tells Brazil travelers get a yellow fever vaccination — and it might be hard to find

By on .

Plan ahead . . .  FDA-approved shot is unavailable, and with limited availability of alternative vaccine, getting inoculated may be a journey in itself . . . Following 10 cases of yellow fever linked to travel in Brazil that led to four deaths this year so far, the U.S. Centers for Disease Control and Prevention has […]

Re-emergence of human monkeypox highlights capacity gaps, global health security goals

By on .

About six months ago, the World Health Organization and the U.S. Centers for Disease Control and Prevention brought together researchers, ministries of health staff, global health program and policy leaders, and experts in pox viruses to discuss re-emergence of a disease that has been reported in more countries during the last decade than in the […]

Mixed reactions greet IAS announcement of San Francisco-Oakland as AIDS 2020 conference site

By on .

The selection of San Francisco and Oakland to host the 23rd International AIDS Conference in 2020 speaks to the power of activism over despair, of science over fear, and of ambition over acceptance — at least to some of those, including Congressional representatives, advocacy organizations, and service providers, cheering the announcement released Tuesday. Or it […]

Getting gender into your science means more than “add women and stir”

By on .

The following is a guest post by Jessica Fehringer, PhD, MEASURE Evaluation I’ve worked in research and with researchers for a while, and often I hear people say that it doesn’t make sense to address gender in their research. When we think about science, we think about proving or disproving a hypothesis. In other words, […]

Zero Discrimination also means quality care

By on .

The following is a guest post by Katherine Andrinopoulos, PhD, MEASURE Evaluation, Tulane University This week, the United Nations observed Zero Discrimination Day, meant to promote equality before the law and in practice—including healthcare—throughout all member countries of the UN. In public health, we know that zero discrimination is essentially about fairness. It is fundamental […]

White House budget recognizes global health threats with words, but not dollars with massive cuts to HHS, State Department, USAID

By on .

“U.S. efforts to control the HIV/AIDS epidemic are a direct reflection of U.S. leadership abroad and the goodwill, compassion, and generosity of the American people.” President’s budget proposal for Fiscal Year 2019 The U.S. State Department and USAID would get $25.8 billion — a cut of $9 billion, or 26 percent from the level enacted […]

State Department Global Gag Rule “review” focuses on training, compliance measures

By on .

“Given the expansive nature of the new policy, the Department will undertake a thorough and comprehensive review of the effectiveness and impact of the policy’s application over the next six months, which could include identifying implementation issues, and any other new information affecting implementation going forward. Newly covered programs, including PEPFAR, the President’s Malaria Initiative, […]